http://orcid.org/0000-0003-4612-9830
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anne Lund Krarup, Lone Larsen, Alev Büyükuslu Nayeb, Simon Grøntved, Søren Paaske Johnsen, Mette Esbjørn, Jan Fallingborg, Gunnar Lauge Nielsen, Kristine Allin, Tine Jess & Anne Estrup Olesen. (2023) Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals – a Danish register-based study of a region with 580,000 citizens. Scandinavian Journal of Gastroenterology 58:5, pages 477-482.
Read now
Read now
Karoline Anisdahl, Sandre Svatun Lirhus, Asle W. Medhus, Bjørn Moum, Hans Olav Melberg & Marte Lie Høivik. (2021) First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study. Scandinavian Journal of Gastroenterology 56:10, pages 1163-1168.
Read now
Read now
Niels Qvist, Kasper Vadstrup, Sarah Alulis, Andras Borsi, Pia Munkholm & Jens Olsen. (2021) Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn’s disease and ulcerative colitis – a Danish register-based study from 2003–2016. Scandinavian Journal of Gastroenterology 56:5, pages 537-544.
Read now
Read now
Articles from other publishers (9)
Jingjing Yang, Jianlin Ke, Xueliang Jiang & Lei Wang. (2023) The association between ulcerative colitis and COVID-19 severity: a systematic review and meta-analysis systematic review. International Journal of Colorectal Disease 39:1.
Crossref
Crossref
Rahul S Dalal, Ken Lund, Floor D Zegers, Sonia Friedman, Jessica R Allegretti & Bente Mertz Nørgård. (2023) Use of Tramadol vs Traditional Opioids and Adverse Outcomes in Patients with Inflammatory Bowel Disease: A Danish Nationwide Cohort Study. Inflammatory Bowel Diseases.
Crossref
Crossref
Mostafa Abd Alfattah Shamkh, Mohamed Amin Sakr, Waleed Hamed Abd Alaty, Shimaa Youssef Kamel, Mohamed Mahmoud Eltabbakh, Ahmed Fouad Sherief, Heba Rashad & Safaa Askar. (2022) A decade of inflammatory bowel disease: a single center experience in Egypt. The Egyptian Journal of Internal Medicine 34:1.
Crossref
Crossref
Maximilian Kutschera, Valentin Ritschl, Berthold Reichardt, Tanja Stamm, Hans Kiener, Harald Maier, Walter Reinisch, Bernhard Benka & Gottfried Novacek. (2022) Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. Journal of Clinical Medicine 11:18, pages 5308.
Crossref
Crossref
Jeremy S Nayagam, Mandour O Mandour, Alison Taylor, Michael A Heneghan, Patrick CA Dubois, Bu Hayee, Huey Miin Lee, Babu Vadamalayan, Marianne Samyn, Deepak Joshi & Alexandra J Kent. (2022) Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 46:7, pages 101980.
Crossref
Crossref
Katsumasa Nagano, Yuya Imai, Yoshifumi Ukyo, Taku Kobayashi & Seiji Yokoyama. (2022) Early-Phase Partial Mayo Score following Golimumab Treatment Is Associated with Endoscopic Improvement at 1 Year in Ulcerative Colitis: A post hoc Analysis of PURSUIT-J Randomized Controlled Trial. Inflammatory Intestinal Diseases 7:3-4, pages 155-162.
Crossref
Crossref
Lynn Huynh, Steve Hass, Laurent Peyrin-Biroulet, Mei Sheng Duh, Heather Sipsma, Mu Cheng, Angie Lax & Arpita Nag. (2022) Real-World Treatment Patterns and Physician Preferences for Biologics in Moderate-to-Severe Inflammatory Bowel Disease: Retrospective Chart Review in Europe. Crohn's & Colitis 360 4:1.
Crossref
Crossref
Gil Berkovitch, Shlomi Cohen, Ronit Lubetzky, Dana Singer & Anat Yerushalmy-Feler. (2021) Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD. BMC Pediatrics 21:1.
Crossref
Crossref
Nastaran Samimi, Masood Sepehrimanesh, Omid Koohi-Hosseinabadi, Reza Homayounfar, Maral Mokhtari & Mojtaba Farjam. (2020) The Therapeutic Effect of Shark Liver Oil in a Rat Model of Acetic Acid-Induced Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-8.
Crossref
Crossref